Julie A Anderson

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Chronic Obstructive Pulmonary Disease

Body Composition

Top Venues

ERJ open research

International journal of chronic obstructive pulmonary disease

The European respiratory journal

GlaxoSmithKline Plc

This page only lists publications with an associated author ORCID identifier.

Affiliation History

GlaxoSmithKline Plc Jan 01 1997

United Kingdom

Director Statistics :: Clinical Statistics

Publications

Emily P Brigham, Julie A Anderson, Robert D Brook, Peter M A Calverley, Bartolome R Celli, Nicholas J Cowans, Courtney Crim, James E Diserens, Fernando J Martinez, Meredith C McCormack, David E Newby, Julie Yates, Jorgen Vestbo, Tianshi David Wu, Robert A Wise
Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial. ERJ open research 7 (3) (2021)
Andras Bikov, Peter Lange, Julie A Anderson, Robert D Brook, Peter M A Calverley, Bartolome R Celli, Nicholas J Cowans, Courtney Crim, Ian J Dixon, Fernando J Martinez, David E Newby, Julie C Yates, Jorgen Vestbo
FEV1 is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease. International journal of chronic obstructive pulmonary disease 15 (2020)
Bartolome R Celli, Julie A Anderson, Robert D Brook, Peter M A Calverley, Nicholas J Cowans, Courtney Crim, Fernando Martinez, David E Newby, Julie Yates, Jørgen Vestbo
Regional differences in rate of FEV1 decline in COPD: lessons from SUMMIT. The European respiratory journal 53 (6) (2019)